Standout Papers

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials 2010 2026 2015 2020 1.4k
  1. Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials (2014)
    Richard G. Langley, Boni E. Elewski et al. New England Journal of Medicine
  2. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial (2013)
    Iain B. McInnes, Arthur Kavanaugh et al. The Lancet
  3. Epidemiology of atopic dermatitis in adults: Results from an international survey (2018)
    S. Barbarot, S. Auziere et al. Allergy
  4. Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions (2010)
    Batya B. Davidovici, Naveed Sattar et al. Journal of Investigative Dermatology
  5. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial (2014)
    Christopher T. Ritchlin, Proton Rahman et al. Annals of the Rheumatic Diseases
  6. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials (2018)
    Kenneth B. Gordon, Bruce Strober et al. The Lancet
  7. Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey (2014)
    Mark Lebwohl, H. Bachelez et al. Journal of the American Academy of Dermatology

Immediate Impact

2 by Nobel laureates 13 from Science/Nature 87 standout
Sub-graph 1 of 18

Citing Papers

Mechanically robust and personalized silk fibroin-magnesium composite scaffolds with water-responsive shape-memory for irregular bone regeneration
2024 Standout
IL-17 and IL-17-producing cells in protection versus pathology
2022 Standout
41 intermediate papers

Works of L. Puig being referenced

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
2014 Standout
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
2012
and 35 more

Author Peers

Author Last Decade Papers Cites
L. Puig 10766 7372 3649 617 17.5k
C. Paul 8430 8425 2895 409 15.9k
Richard G. Langley 14165 9354 3341 255 18.4k
P.C.M. van de Kerkhof 8645 7810 1780 495 15.4k
Alan Menter 18409 11772 4555 375 24.5k
Giampiero Girolomoni 12086 9588 3699 539 23.0k
Kristian Reich 19466 13460 4889 491 25.3k
Alice B. Gottlieb 22317 11858 8621 573 30.3k
Wolf‐­Henning Boehncke 8415 4271 2658 355 12.9k
Enno Christophers 9842 5808 1904 357 18.5k
Mark Lebwohl 22034 17465 5458 807 34.6k

All Works

Loading papers...

Rankless by CCL
2026